In our study, we found that the BCL2 rs1564483A allele was associated with a significantly favorable survival of male advanced NSCLC patients, especially in smoking patients and patients underwent chemo- or radio-therapy. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.